What is growth hormone?
Human growth hormone (HGH, also called somatropin) is a hormone your pituitary gland makes naturally. In childhood it drives growth; throughout life it helps regulate body composition, metabolism, bone strength, and how the body uses fats, proteins, and carbohydrates. Levels peak in youth and decline gradually with age, which is normal physiology rather than a disease.
The therapeutic form, recombinant human growth hormone, is molecularly identical to what the body makes, and it exists to replace what is missing in people with a diagnosed growth hormone deficiency. That word, diagnosed, is the hinge of this entire article, because HGH is two different stories: a well-evidenced, FDA-approved replacement therapy in deficiency, and a famous enhancement idea whose evidence and legal footing are entirely different.
How does it work?
The pituitary releases growth hormone in pulses. It acts directly on tissues and indirectly by prompting the liver to produce IGF-1, and together those signals shape muscle and bone, fat metabolism, and tissue maintenance. When the pituitary genuinely underproduces, the whole cascade is blunted, showing up as increased visceral fat, reduced lean mass and bone density, unfavorable lipids, and impaired quality of life.
Replacement restores the signal toward normal in people measured to be deficient. Like all hormone replacement done well, the goal is correcting a measured shortfall, not pushing levels above normal, and that distinction carries the safety story.
Why it matters in regenerative medicine
Growth hormone sits at the center of the body-composition biology this whole field cares about, and adult deficiency is real, underdiagnosed, and worth treating: modern reviews report that proper replacement brings mortality in deficient adults close to that of the general population. The regenerative-medicine angle is therefore mostly diagnostic: knowing when a tired, softening, slow-recovering adult is actually deficient, which is established by endocrine stimulation testing rather than by age or symptoms alone. For everyone else, the upstream secretagogues covered elsewhere in this library exist precisely because they work with the body's own feedback rather than overriding it.
What the evidence shows
In diagnosed deficiency, the evidence is deep and modern. Two 2021 reviews in Reviews in Endocrine and Metabolic Disorders lay out current diagnostic practice, the consequences of untreated deficiency, and the survival benefits of replacement. The interventional record now includes phase 3 trials of long-acting forms: a 2020 randomized controlled trial of once-weekly somapacitan in deficient adults found significant reductions in truncal and visceral fat and improved lean mass versus placebo, with safety in line with daily growth hormone, and the foresiGHt trial (NCT04615273) compared once-weekly lonapegsomatropin against both placebo and daily somatropin in 264 deficient adults.
Recombinant somatropin itself (Genotropin and similar) carries decades of approved use in children and adults with deficiency. Within its lane, this is one of the best-evidenced hormones in medicine.
The enhancement question, answered honestly
The elephant in this article is anti-aging use, so here is the straight version. The strong evidence lives in diagnosed deficiency; trials of growth hormone in healthy older adults have shown modest body-composition shifts alongside real side effects, and no demonstrated benefit to the things people actually want: function, healthspan, longevity. Normal age-related decline is not deficiency, and treating it as such inverts the risk-benefit math that makes replacement therapy work.
There is also a legal wall many people never hear about: in the United States, distributing growth hormone for anti-aging or enhancement is not a gray area but a federal offense, which is why legitimate practice runs through diagnosis. Anyone whose symptoms genuinely suggest deficiency deserves the real workup, because the treatable condition exists and testing settles it.
The pros and the cons
What's promising
- FDA-approved, with decades of evidence in diagnosed deficiency in children and adults.
- Replacement in deficient adults improves body composition, bone, lipids, and quality of life.
- Modern once-weekly forms are validated by phase 3 trials, easing the old daily-injection burden.
- Proper treatment normalizes mortality in the deficient population toward general levels.
What's uncertain
- Outside diagnosed deficiency, benefit is undemonstrated and side effects are real.
- Anti-aging distribution is a federal offense in the US, not an off-label gray zone.
- Supra-physiological levels carry known risks: glucose effects, fluid retention, joint symptoms.
- Age-related decline mimics deficiency symptoms, which fuels misdiagnosis and mis-selling.
Worth considering
- The stimulation test is the gate: symptoms plus low-normal labs are not a diagnosis.
- If deficiency is confirmed, replacement is legitimate, evidenced medicine with monitoring.
- If it is not, the upstream secretagogue conversation (tesamorelin, and the peptides in this library) is the honest alternative discussion to have with a physician.
- IGF-1 and glucose monitoring are standard on any growth-hormone therapy.
Why the evidence looks the way it does
Growth hormone got the full pharmaceutical treatment, decades of funded trials, because deficiency is a defined disease with a defined product. The enhancement question never got equivalent trials for the opposite reason: no sponsor can own the answer, and regulators forbid the use anyway. So the deficiency evidence is excellent, the enhancement evidence is thin and unflattering, and the gap between them is where most HGH marketing lives. This article exists so our readers stand on the evidence side of that gap.
What the key trials tested
Our framing rule for evidence: a trial tests one form, one dose, one population, one endpoint. Where the evidence sits:
Preclinical & practice
The anti-aging and enhancement uses: undemonstrated benefit, known side effects, legal restrictions.
Early trials
Ongoing refinements of dosing and delivery in deficient populations.
Late-stage trials
Phase 3 programs for once-weekly somapacitan and lonapegsomatropin in diagnosed deficiency.
Approved uses
Growth hormone deficiency in children and adults, plus several pediatric growth conditions.
Every study behind this article is filterable in our research library on the Science page.
Questions people ask
How do I know if I am actually deficient?
Not by symptoms or age, both of which overlap completely with normal aging. Adult growth hormone deficiency is established by endocrine stimulation testing, in which the pituitary is provoked and its response measured. If the workup confirms deficiency, replacement is legitimate, well-evidenced medicine; if it does not, the honest conversation moves to other tools.
Does HGH reverse aging?
No trial has shown that. In healthy older adults, growth hormone produces modest body-composition changes along with real side effects, fluid retention, joint symptoms, glucose effects, and no demonstrated improvement in function or longevity. The impressive evidence all lives in diagnosed deficiency, where a missing signal is being restored rather than a normal one amplified.
Is HGH legal for anti-aging?
In the United States, no: distributing growth hormone for anti-aging or enhancement is a federal offense, a stricter rule than ordinary off-label prescribing. That is why legitimate use runs through a real diagnosis, and why offers of easy HGH without testing deserve suspicion on legal grounds before scientific ones.
What are the alternatives if I am not deficient?
The upstream approach: compounds that prompt your own pituitary rather than replacing its output, preserving feedback control. Tesamorelin is the approved example, and the secretagogue peptides covered elsewhere in this library are the investigational ones. Different evidence levels, same principle, and all of it is physician-conversation territory.
What to take away
If you remember five things from this article, make them these:
- HGH is two stories: excellent, approved medicine in diagnosed deficiency, and an enhancement idea without the evidence.
- Deficiency is established by stimulation testing, never by symptoms or age alone.
- Replacement in the truly deficient improves body composition, bone, lipids, and survival.
- Anti-aging distribution is illegal in the US, and the healthy-adult trials showed side effects without functional benefit.
- Not deficient? The upstream secretagogue conversation with a physician is the honest next step.
The evidence
Selected references, each verified against primary sources (PubMed, ClinicalTrials.gov, and the FDA label). Explore the full, filterable research library on our Science page.
This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Growth Hormone (HGH) is discussed in the context of the published research; inclusion of a study does not imply a guaranteed outcome. Many of these compounds are investigational and not approved for the uses described in all jurisdictions. Any treatment decision should be made with a qualified physician. Individual results vary.